Shinobu Hosokawa Selected Research

Shinobu Hosokawa Research Topics

Disease

27	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2022 - 07/2004
9	Lung Neoplasms (Lung Cancer) 02/2021 - 10/2007
6	Neoplasms (Cancer) 12/2021 - 07/2012
5	Myocardial Infarction 05/2011 - 11/2005
2	Pneumonia (Pneumonitis) 01/2022 - 12/2020
2	Adenocarcinoma of Lung 01/2021 - 12/2014
2	Disease Progression 01/2020 - 01/2013
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 10/2016 - 10/2011
2	Thrombosis (Thrombus) 01/2012 - 05/2011
1	Idiopathic Interstitial Pneumonias 01/2022
1	Febrile Neutropenia 09/2021
1	Esophagitis 09/2021
1	Dysbiosis 01/2021
1	Interstitial Lung Diseases (Interstitial Lung Disease) 12/2020
1	Anorexia 01/2020
1	Diarrhea 01/2020
1	Erythema Multiforme 01/2020
1	Stomatitis 01/2020
1	Paronychia 01/2020
1	Melanoma (Melanoma, Malignant) 01/2020
1	Stroke (Strokes) 10/2019
1	Paradoxical Embolism 10/2019
1	Leukopenia 11/2018
1	Hemoptysis 08/2018
1	Pulmonary Aspergillosis 08/2018
1	Aortic Valve Stenosis (Aortic Stenosis) 04/2018
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 03/2015
1	Exanthema (Rash) 03/2015
1	Hypertension (High Blood Pressure) 03/2015
1	Proteinuria 03/2015
1	Intracranial Sinus Thrombosis (Sinus Thrombosis) 12/2014
1	Meningeal Carcinomatosis 12/2014
1	Brain Neoplasms (Brain Tumor) 12/2014
1	Infections 01/2013
1	Chest Pain (Chest Pains) 01/2013
1	Toothache (Toothaches) 01/2013
1	Neointima 01/2012
1	Ischemia 01/2012
1	Hemorrhage 05/2011
1	Insulin Resistance 03/2010
1	Second Primary Neoplasms (Neoplasms, Second) 10/2007
1	Hyperlipidemias (Hyperlipidemia) 08/2006

Drug/Important Bio-Agent (IBA)

9	Immune Checkpoint InhibitorsIBA 12/2021 - 01/2020
8	ErbB Receptors (EGF Receptor)IBA 01/2021 - 12/2014
3	amrubicinIBA 01/2021 - 10/2011
3	130-nm albumin-bound paclitaxelIBA 01/2020 - 11/2018
3	Anaplastic Lymphoma KinaseIBA 08/2019 - 03/2016
3	Cisplatin (Platino)FDA LinkGeneric 10/2016 - 10/2007
2	LigandsIBA 07/2022 - 01/2020
2	atezolizumabIBA 01/2022 - 12/2020
2	B7-H1 AntigenIBA 12/2021 - 02/2021
2	Anti-Bacterial Agents (Antibiotics)IBA 11/2021 - 01/2021
2	Programmed Cell Death 1 ReceptorIBA 02/2021 - 01/2020
2	CrizotinibIBA 01/2021 - 03/2016
2	alectinibIBA 01/2021 - 03/2016
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2021 - 01/2020
2	Tyrosine Kinase InhibitorsIBA 01/2021 - 01/2020
2	Carboplatin (JM8)FDA LinkGeneric 01/2020 - 11/2018
2	Topotecan (Hycamtin)FDA LinkGeneric 10/2016 - 10/2011
2	Gefitinib (Iressa)FDA Link 03/2015 - 12/2014
2	Irinotecan (Camptosar)FDA LinkGeneric 07/2012 - 07/2004
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 08/2006 - 11/2005
2	Acetylcholine (Acetylcholine Chloride)FDA Link 05/2005 - 03/2003
1	pembrolizumabIBA 07/2022
1	Biomarkers (Surrogate Marker)IBA 12/2021
1	AlginatesIBA 09/2021
1	dacomitinibIBA 01/2021
1	AntibodiesIBA 01/2020
1	AnticoagulantsIBA 10/2019
1	Albumin-Bound Paclitaxel FDA Link 08/2019
1	Pharmaceutical PreparationsIBA 01/2019
1	SiliconesIBA 08/2018
1	IceIBA 04/2018
1	Phosphotransferases (Kinase)IBA 03/2016
1	tyrosine receptor (receptor, tyrosine)IBA 03/2016
1	Bevacizumab (Avastin)FDA Link 03/2015
1	Alanine Transaminase (SGPT)IBA 03/2015
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 03/2015
1	Warfarin (Coumadin)FDA LinkGeneric 12/2014
1	Heparin (Liquaemin)FDA LinkGeneric 12/2014
1	LipidsIBA 01/2012
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 05/2011
1	Fluorouracil (Carac)FDA LinkGeneric 01/2011
1	HDL CholesterolIBA 03/2010
1	Dihydrotachysterol (AT 10)IBA 10/2007
1	CarcinogensIBA 10/2007
1	ThalliumIBA 04/2007
1	pentadecanoic acidIBA 04/2007
1	iodofiltic acidIBA 04/2007
1	Indicators and Reagents (Reagents)IBA 04/2007
1	CholesterolIBA 08/2006

Therapy/Procedure

10	Radiotherapy 08/2021 - 10/2007
9	Therapeutics 07/2022 - 11/2005
6	Drug Therapy (Chemotherapy) 01/2020 - 10/2007
4	Stents 01/2012 - 04/2002
1	Chemoradiotherapy 09/2021
1	Retreatment 01/2021
1	Tooth Extraction (Tooth Extractions) 01/2013
1	Drug-Eluting Stents 01/2012
1	Percutaneous Coronary Intervention 03/2007